Zeus appointed as Broker to Cizzle Biotechnology Holdings plc

We are delighted to announce that Zeus has been appointed as Broker to Cizzle Biotechnology Holdings plc (CIZ).

Cizzle Biotechnology Holdings plc is a pioneering cancer diagnostics company, originally a spin-out from the University of York, and now listed on the London Stock Exchange. Cizzle has developed a non-invasive blood test for early lung cancer detection, using their patented CIZ1B biomarker technology.

Contact

If you would like further information, please get in touch with our team.

James Hornigold Director+44 203 829 5000+44 7860 843 020LinkedIn Scan with your phone camera to add to contacts Download vCard

Recent news

Sosandar plc

Zeus appointed as Broker to Sosandar plc

25 June 2026
Empire Metals Ltd

Zeus appointed as Joint Broker to Empire Metals Ltd

4 June 2026
Company news

Zeus appoints John Cummins as Chief Executive Officer

20 May 2026
Company news

Delivering for our clients

27 April 2026
SEEEN plc

Zeus appointed as Nomad & Broker to SEEEN plc

20 April 2026
Sintana Energy Inc

Zeus is delighted to have acted as Nomad and Joint Broker to Sintana Energy Inc. on its admission to AIM

27 February 2026
Uncategorised

Zeus Internship now open

16 February 2026
RTC Group plc

Zeus appointed as Broker to RTC Group plc

17 December 2025